1.
Thrombelastograph examination in patients with chronic myeloproliferative disease
慢性骨髓增殖性疾病患者TEG检测的变化
2.
Study on Expression of JAK2 Mutation in Patients with Chronic Myeloproliferative Diseases and Its Targeted Therapy in Vitro;
慢性骨髓增殖性疾病JAK2基因突变发生情况及其靶向治疗的研究
3.
Clinic Study on Expression of JAK2 and MPL Mutations in Patients with Chronic Myeloproliferative Diseases;
慢性骨髓增殖性疾病JAK2及MPL基因突变的临床研究
4.
Identification of an JAK2 Mutation in Chronic Myeloproliferative Disorders by dFARMS;
dFARMS检测慢性骨髓增殖性疾病JAK2基因的V617F点突变的研究
5.
Detection of V617F point mutation of JAK2 gene by AS-PCR in chronic myeloproliferative disease and its clinical significance
AS-PCR检测慢性骨髓增殖性疾病JAK2 V617点突变及临床意义
6.
Clinical Analysis of 126 Cases of Myeloproliferative Disease
骨髓增殖性疾病126例临床病例分析
7.
The Study of Tyrosine Kinase JAK2V617F Mutation in Human Myeloproliferative Disorders;
骨髓增殖性疾病JAK2V617F点突变研究
8.
Advance of Study on JAK2 V617F in Myeloproliferative Disorders--Review
骨髓增殖性疾病JAK2 V617F研究进展
9.
JAK2V617F Point Mutation in Hematological Malignancies;
慢性骨髓增生性疾病JAK2基因V617F点突变研究
10.
Discussion of MD/MPD by the way of deficiency of the vital essestial and blood stasis
从正虚瘀结论治骨髓增生异常/骨髓增殖性疾病初探
11.
Analysis of clinical and biological characteristics of myeloplastic and myeloproliferative disorders in children
儿童骨髓增生异常/骨髓增殖性疾病临床及生物学特征分析
12.
The Expressions and Clinical Significance of JAK2V617F Mutation in the Patients with Myeloproliferative Disorders;
JAK2V617F突变在骨髓增殖性疾病中的表达及临床研究
13.
Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.
这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。
14.
A Study on the Correlation between JAK2V617F Mutation and the Expression Level of Cytokine Receptors in Myeloproliferative Disorders;
骨髓增殖性疾病中JAK2V617F突变与细胞因子受体表达的相关性研究
15.
The Study of Tyrosine Kinase JAK2V617F Mutation in Human Myeloproliferative Disorders of Qinghai Province
蛋白激酶JAK2V617F点突变在青海省骨髓增殖性疾病中表达的相关性研究
16.
JAK2 V617F mutation in BCR-ABL negative patients with myeloproliferative disorder and its clinic significance
BCR-ABL阴性骨髓增殖性疾病患者JAK2 V617F突变的检测及其临床意义
17.
Study on JAK2 V617F point mutation in 141 patients with chronic myeloproliferatives diseases
141例慢性骨髓增生性疾病中JAK2基因V617F点突变的研究
18.
Roles and Significances of JAK2V617F Mutation in Myeloproliferative Disorders;
JAK2V617F突变在骨髓增殖性疾病中的意义及其机制探讨